Dr. Reddy's Laboratories Ltd.

BSE

Price on BSE 27 Mar,15:29 LIVE

1,286.20

-15.70

(-1.21%)

Volume :
55,880.00

Prev Close :
1,301.90

Day's H/L (Rs.) :
1,302.00 - 1,274.75

52wk H/L (Rs.) :
1,377.95 - 1,025.90

Mkt Cap (Rs. Cr) :
107,359.12

NSE

Price on NSE 27 Mar,15:59 LIVE

1,281.70

-19.00

(-1.46%)

Volume :
2,165,113.00

Prev Close :
1,300.70

Day's H/L (Rs.) :
1,302.90 - 1,278.20

52wk H/L (Rs.) :
1,379.70 - 1,020.00

Mkt Cap (Rs. Cr) :
0.00

Market News

Semaglutide Ruling Sparks Generic Pharma Boom
Rediff.com 3 day(s) ago

Vet killed by hippo during treatment at Shivamogga zoo
Rediff.com 20 Mar 2026

Non-US uptick seen driving gains for Dr Reddy's Labs
Rediff.com 23 Jan 2026

Dr Reddy's profit down 14% on low Lenalidomide US sales
Rediff.com 22 Jan 2026

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?
Rediff.com 11 Mar 2026

Report Card - Dr. Reddy's Laboratories Ltd.

PE Ratios

20.05

EPS (Rs.)

64.14

Sales (Rs. Cr)

4,282.70

Face Value (Rs.)

Net Profit Margin(%)

23.14

Last Bonus

1:1

Last Dividend(%)

800

Return on Average Equity

18.53

News for Dr. Reddy's Laboratories Ltd.

Dr Reddy''s: US SEC Ends Investigation

US SEC concludes investigation into Dr Reddy''s. No enforcement action recommended after probe into improper payments allegations.

Feb 24, 2026 21:16

Dr Reddy''s Enters Hormone Replacement Therapy

Dr Reddy''s acquires Progynova & Cyclo-Progynova for USD 32.15 mn, entering the hormone replacement therapy market in India. Strengthens gynaecology portfolio.

Feb 19, 2026 08:58

Dr Reddy''s Q3 Profit Dips 14% to Rs 1,210 Cr

Dr Reddy''s Q3FY26 profit declines 14% to Rs 1,210 crore due to lower US sales. Revenue rises to Rs 8,727 crore. India sales up 19%.

Jan 21, 2026 18:20

Dr Reddy''s & Immutep Ink Cancer Drug Licensing Pact

Dr Reddy''s and Immutep collaborate to develop and commercialize Eftilagimod Alfa (Efti), a cancer medication, outside key markets.

Dec 08, 2025 14:49

Dr Reddy''s Biosimilar Approved in Europe

Dr Reddy''s gets EU nod for AVT03, a biosimilar of Prolia (denosumab) and Xgeva, used to treat osteoporosis and prevent bone complications.

Nov 24, 2025 17:22

More News for Dr. Reddy's Laboratories Ltd. »

News for Pharmaceuticals and health care

Luxury Travel Resilient, Say Hotel Execs

Hotel executives express confidence in luxury travel's quick recovery despite geopolitical conflicts. Learn about resilience and market recovery.

Mar 27, 2026 22:33

Radisson Resort Kalimpong: First International Resort

Radisson Hotel Group signs first internationally branded resort in Kalimpong, West Bengal. Expands footprint in leisure markets.

Mar 27, 2026 22:23

RBI Payments Vision 2028: E-Cheques & Digital Payment Regulation

RBI unveils Payments Vision 2028: e-cheques, wider digital payment regulation, shared responsibility, fraud prevention, & more.

Mar 27, 2026 21:42

Oriental Insurance Crosses Rs 20,000 Cr Premium

Oriental Insurance Company Ltd (OICL) crosses Rs 20,000 crore in gross premium for FY26. Growth driven by GPA, Health, Fire, Motor insurance.

Mar 27, 2026 21:25

RBI Sets WMA Limit for Govt at Rs 2.5 Lakh Crore

RBI fixes H1 WMA limit for govt at Rs 2.5 lakh crore to address temporary mismatches in receipts and payments. Details inside.

Mar 27, 2026 20:46

More News »

Top News

Metro Railways Law Amendments: Increased Penalties

Centre proposes amendments to Metro Railways Act, increasing penalties for offences like drunkenness and unlawful entry.

Mar 27, 2026 23:32

India AI Skilling Initiative Launched in Africa

JNS Cloud Solutions launches AI skilling initiative in Africa with upGrad Enterprise. Focus on digital transformation and employability.

Mar 27, 2026 23:25

Luxury Travel Resilient, Say Hotel Execs

Hotel executives express confidence in luxury travel's quick recovery despite geopolitical conflicts. Learn about resilience and market recovery.

Mar 27, 2026 22:33

RERA: Imprisonment Provision for Allottees to Be Removed

Centre proposes removing 1-year jail for allottees failing to comply with Real Estate Appellate Tribunal orders. Penalty up to 10% of property cost.

Mar 27, 2026 22:28

Radisson Resort Kalimpong: First International Resort

Radisson Hotel Group signs first internationally branded resort in Kalimpong, West Bengal. Expands footprint in leisure markets.

Mar 27, 2026 22:23

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist